Julius Clinical is attending the MASH Drug Development Summit 2026 in Boston.

P95 Julius Clinical is a global, science-led contract research organization (CRO) supporting clinical development from early-phase trials through late-phase and real-world evidence programs. The company specializes in complex research for biotech and pharmaceutical sponsors, with deep expertise across neuroscience, infectious diseases and vaccines, and cardiovascular, renal, and metabolic diseases. Backed by a leadership of scientific luminaries and more than 500 experts spanning five continents, P95 Julius Clinical combines the reach of a larger CRO with the agility of a mid-sized partner.